Paul Browne

5.5k total citations · 2 hit papers
68 papers, 3.7k citations indexed

About

Paul Browne is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Paul Browne has authored 68 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 28 papers in Genetics and 15 papers in Immunology. Recurrent topics in Paul Browne's work include Chronic Lymphocytic Leukemia Research (13 papers), Hemoglobinopathies and Related Disorders (11 papers) and Lymphoma Diagnosis and Treatment (10 papers). Paul Browne is often cited by papers focused on Chronic Lymphocytic Leukemia Research (13 papers), Hemoglobinopathies and Related Disorders (11 papers) and Lymphoma Diagnosis and Treatment (10 papers). Paul Browne collaborates with scholars based in Ireland, United States and United Kingdom. Paul Browne's co-authors include Robert P. Hebbel, Anna Solovey, Elizabeth A. Wayner, Yi Lin, Stephana Choong, Modupe Elebute, Peter Hillmen, Gèrard Socié, Jörg Schubert and Petra Muus and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Paul Browne

65 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

2006 878 citations Peter Hillmen, Neal S. Young et al. New England Journal of Medicine profile →
Circulating Activated Endothelial Cells in Sickle Cell Anemia

1997 509 citations Anna Solovey, Paul Browne et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Browne Ireland	26	1.5k	1.3k	956	858	678	68	3.7k
Roshini S. Abraham United States	32	1.7k 1.1×	1.2k 0.9×	704 0.7×	1.7k 2.0×	439 0.6×	126	4.4k
Austin Kulasekararaj United Kingdom	35	2.1k 1.4×	3.3k 2.5×	1.5k 1.6×	880 1.0×	873 1.3×	207	5.1k
Elaine M. Sloand United States	43	1.4k 1.0×	2.5k 1.9×	785 0.8×	991 1.2×	164 0.2×	117	4.8k
Nicole A. Aqui United States	18	1.3k 0.9×	862 0.7×	569 0.6×	295 0.3×	344 0.5×	41	3.4k
Petra Muus Netherlands	37	2.6k 1.8×	3.3k 2.5×	1.4k 1.4×	1.2k 1.4×	1.4k 2.1×	176	5.8k
Maria Greenwald United States	30	1.5k 1.0×	1.2k 0.9×	868 0.9×	607 0.7×	198 0.3×	76	5.1k
Jacob H. Rand United States	40	1.0k 0.7×	2.9k 2.2×	355 0.4×	808 0.9×	642 0.9×	125	5.8k
Cheryl Yarboro United States	31	2.6k 1.8×	596 0.5×	388 0.4×	495 0.6×	740 1.1×	51	5.3k
Sung‐Soo Yoon South Korea	35	630 0.4×	1.8k 1.4×	637 0.7×	1.6k 1.9×	229 0.3×	342	4.2k
Jens Panse Germany	25	917 0.6×	705 0.5×	407 0.4×	360 0.4×	244 0.4×	154	2.2k

Countries citing papers authored by Paul Browne

Since Specialization

Citations

This map shows the geographic impact of Paul Browne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Browne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Browne more than expected).

Fields of papers citing papers by Paul Browne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Browne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Browne. The network helps show where Paul Browne may publish in the future.

Co-authorship network of co-authors of Paul Browne

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Browne. A scholar is included among the top collaborators of Paul Browne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Browne. Paul Browne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Groarke, Emma M., Fernanda Gutierrez‐Rodrigues, Xiaoyang Ma, et al.. (2021). U2AF1 and Other Splicing Factor Gene Mutations in Telomere Biology Disorders Are Associated with Hematologic Neoplasia and Worse Overall Survival. Blood. 138(Supplement 1). 862–862. 2 indexed citations

Muthukrishnan, Arvind, Saad Al‐Ismail, Gianfilippo Bertelli, & Paul Browne. (2017). MRONJ risk reduction pathway - 360 degree survey. BDJ. 222(5). 386–390. 4 indexed citations

O’Reilly, Vincent, et al.. (2017). Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8+ invariant natural killer T cells. Clinical Immunology. 183. 91–98. 17 indexed citations

Matthew, Matthew, et al.. (2015). 100 classic papers of interventional radiology: A citation analysis. 79–86. 2 indexed citations

Lysaght, Joanne, Navin Kumar Verma, Jacqueline Ryan, et al.. (2012). The microtubule targeting agent PBOX-15 inhibits integrin-mediated cell adhesion and induces apoptosis in acute lymphoblastic leukaemia cells. International Journal of Oncology. 42(1). 239–246. 9 indexed citations

Langabeer, Stephen E., et al.. (2012). Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia. Leukemia Research. 36(4). 483–484. 23 indexed citations

Gilmore, Ruth, Lorraine Brennan, Shaun R. McCann, et al.. (2010). T-lymphoblastic leukemia/lymphoma: a single center retrospective study of outcome. Leukemia & lymphoma. 51(6). 1035–1039. 7 indexed citations

Browne, Paul, Patrick Hayden, Elisabeth Vandenberghe, et al.. (2010). PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells. British Journal of Cancer. 104(2). 281–289. 27 indexed citations

Greene, Lisa M., Siobhan McGuckin, Paul Browne, et al.. (2009). The Novel Tubulin-Targeting Agent Pyrrolo-1,5-Benzoxazepine-15 Induces Apoptosis in Poor Prognostic Subgroups of Chronic Lymphocytic Leukemia. Cancer Research. 69(21). 8366–8375. 30 indexed citations

10.

Ryan, Jacqueline, Fiona Quinn, Ludmila Boublíková, et al.. (2008). Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time‐points reveals high levels of concordance between molecular and immunophenotypic approaches. British Journal of Haematology. 144(1). 107–115. 42 indexed citations

11.

Muus, Petra, Eric Van Den Neste, Ulrich Duehrsen, et al.. (2007). The clinical benefit of eculizumab is demonstrable in all subpopulations of patients with paroxysmal nocturnal hemoglobinuria (PNH) with hemolysis. 92. 137–138. 1 indexed citations

12.

Hillmen, Peter, Neal S. Young, Jörg Schubert, et al.. (2006). The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria. New England Journal of Medicine. 355(12). 1233–1243. 878 indexed citations breakdown →

13.

Boublíková, Ludmila, Markéta Kalinová, Jacqueline Ryan, et al.. (2005). Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring. Leukemia. 20(2). 254–263. 75 indexed citations

14.

Bradley, et al.. (2003). Environmental Noise Modelling for UK Military Helicopter Training Operations.

15.

O’Brien, David, et al.. (2003). Haemoglobin Etobicoke, an incidental finding in an Irish diabetic. Clinical & Laboratory Haematology. 25(4). 259–262. 4 indexed citations

16.

Hennessy, Bryan T., John A. McCaffrey, Peter A. Daly, Paul Browne, & Michael J. Kennedy. (2002). High dose chemotherapy and stem cell support for poor risk and recurrent nonseminomatous germ cell cancer: initial experience with sequential therapy. Irish Journal of Medical Science (1971 -). 171(3). 158–160. 1 indexed citations

17.

Gardiner, Natalie J., et al.. (1998). Absence of HHV8/KSHV DNA in peripheral blood and bone marrow harvests from patients with multiple myeloma. British Journal of Cancer. 78. 24–24. 7 indexed citations

18.

Browne, Paul, O Shalev, F A Kuypers, et al.. (1997). Removal of erythrocyte membrane iron in vivo ameliorates the pathobiology of murine thalassemia.. Journal of Clinical Investigation. 100(6). 1459–1464. 30 indexed citations

19.

Browne, Paul, et al.. (1996). Disturbance of plasma and platelet thrombospondin levels in sickle cell disease. American Journal of Hematology. 51(4). 296–301. 81 indexed citations

20.

Detwiler, Thomas C., et al.. (1992). Complexes of Thrombin with Proteins Secreted by Activated Platelets. Seminars in Thrombosis and Hemostasis. 18(1). 60–66. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact